Breast Cancer
A Discussant will present the most impactful studies from the Breast Cancer track:
* Cosmetic outcome from post lumpectomy whole breast irradiation (WBI) versus partial breast irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial, Julia White
* Quantifying the Impact of Regional Lymph Node Irradiation on Lymphedema Risk in Breast Cancer Patients Treated with SLNB or ALND: Long-Term Results from a Prospective Screening Trial, George Naoum
* Prospective Phase II Clinical Trial of Hypofractionated Radiation in Breast Cancer Patients undergoing Comprehensive Nodal Irradiation for Node Positive Disease, Christine Fisher
* A Prospective Phase I trial of Concurrent Cisplatin (CIS) and Radiation Therapy (RT) in Women with Stage II and III Triple-negative Breast Cancer (TNBC), Jennifer Bellon
The asset you are trying to access is locked. Please enter your access key to unlock.